Neumora Therapeutics, Inc. — SCHEDULE 13G Filings
4 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Neumora Therapeutics, Inc. (NMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Neumora Therapeutics, Inc. has filed 4 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by Neumora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0002005369-26-000014 | Feb 19, 2026 | — |
| SCHEDULE 13G | — | 0000905148-25-002815 | Aug 11, 2025 | — |
| SCHEDULE 13G | — | 0000315066-24-001797 | Jul 8, 2024 | — |
| SCHEDULE 13G | — | 0000315066-24-001795 | Jul 8, 2024 | — |